Best TWAS P=1.47e-11 · Best GWAS P=1.5e-11 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ANXA5 | 0.48 | 0.37 | lasso | 5 | 0.46 | 7.4e-63 | 6.1 | -6.0 | 1.9e-09 | -0.87 | 0.08 | 0.92 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | BBS7 | 0.19 | 0.21 | bslmm | 423 | 0.23 | 1.8e-27 | -5.8 | -5.8 | 5.2e-09 | -0.14 | 0.39 | 0.61 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | KIAA1109 | 0.09 | 0.08 | bslmm | 390 | 0.08 | 8.9e-10 | 4.3 | -5.9 | 4.2e-09 | -0.12 | 0.97 | 0.03 | TRUE |
4 | GTEx | Adipose Subcutaneous | ANXA5 | 0.25 | 0.16 | lasso | 5 | 0.19 | 9.9e-16 | 6.1 | -5.6 | 2.2e-08 | -0.90 | 0.08 | 0.92 | FALSE |
5 | GTEx | Adrenal Gland | ANXA5 | 0.23 | 0.16 | lasso | 4 | 0.15 | 5.3e-06 | 5.2 | -5.9 | 3.7e-09 | -0.92 | 0.02 | 0.97 | FALSE |
6 | GTEx | Artery Aorta | ANXA5 | 0.23 | 0.21 | lasso | 3 | 0.21 | 1.3e-11 | 6.1 | -6.5 | 6.9e-11 | -0.97 | 0.02 | 0.98 | FALSE |
7 | GTEx | Artery Tibial | ANXA5 | 0.32 | 0.22 | lasso | 8 | 0.20 | 1.2e-15 | 6.1 | -6.3 | 3.2e-10 | -0.95 | 0.07 | 0.93 | FALSE |
8 | GTEx | Brain Nucleus accumbens basal ganglia | ANXA5 | 0.46 | 0.26 | lasso | 7 | 0.23 | 9.9e-07 | 6.1 | -6.5 | 1.0e-10 | -0.97 | 0.01 | 0.99 | FALSE |
9 | GTEx | Cells EBV-transformed lymphocytes | EXOSC9 | 0.29 | 0.17 | lasso | 7 | 0.16 | 6.6e-06 | 4.5 | 5.4 | 7.7e-08 | 0.09 | 0.87 | 0.02 | FALSE |
10 | GTEx | Cells Transformed fibroblasts | BBS7 | 0.16 | 0.09 | lasso | 7 | 0.16 | 2.9e-12 | -5.9 | -5.9 | 2.9e-09 | -0.14 | 0.46 | 0.54 | FALSE |
11 | GTEx | Colon Transverse | BBS12 | 0.12 | 0.05 | enet | 29 | 0.12 | 3.2e-06 | -1.6 | 5.4 | 5.7e-08 | 0.01 | 0.03 | 0.52 | FALSE |
12 | GTEx | Muscle Skeletal | ANXA5 | 0.20 | 0.18 | enet | 5 | 0.20 | 3.1e-19 | 6.7 | -6.4 | 1.3e-10 | -0.96 | 0.00 | 1.00 | FALSE |
13 | GTEx | Pituitary | ANXA5 | 0.35 | 0.36 | lasso | 4 | 0.27 | 1.7e-07 | 6.1 | -6.1 | 8.7e-10 | -0.94 | 0.03 | 0.97 | FALSE |
14 | GTEx | Spleen | ANXA5 | 0.42 | 0.28 | lasso | 6 | 0.23 | 1.7e-06 | 6.1 | -5.9 | 3.2e-09 | -0.90 | 0.04 | 0.91 | FALSE |
15 | GTEx | Testis | EXOSC9 | 0.17 | 0.07 | lasso | 8 | 0.10 | 2.5e-05 | -4.3 | 5.6 | 2.5e-08 | 0.14 | 0.58 | 0.22 | FALSE |
16 | GTEx | Testis | ANXA5 | 0.43 | 0.33 | lasso | 3 | 0.32 | 6.3e-15 | 6.1 | -6.2 | 7.1e-10 | -0.93 | 0.08 | 0.92 | FALSE |
17 | GTEx | Thyroid | ANXA5 | 0.29 | 0.18 | lasso | 7 | 0.18 | 1.6e-13 | 6.1 | -6.1 | 9.1e-10 | -0.93 | 0.08 | 0.92 | FALSE |
18 | METSIM | Adipose | ANXA5 | 0.15 | 0.14 | enet | 25 | 0.15 | 4.7e-22 | 6.1 | -5.2 | 1.9e-07 | -0.82 | 0.03 | 0.97 | FALSE |
19 | ROSMAP | Brain Pre-frontal Cortex | ANXA5 | 0.48 | 0.47 | lasso | 9 | 0.49 | 5.3e-72 | 6.1 | -6.1 | 9.5e-10 | -0.92 | 0.09 | 0.91 | FALSE |
20 | The Cancer Genome Atlas | Breast Invasive Carcinoma | EXOSC9 | 0.03 | 0.04 | enet | 9 | 0.04 | 2.8e-08 | 4.5 | 5.5 | 3.1e-08 | 0.08 | 0.59 | 0.40 | FALSE |
21 | The Cancer Genome Atlas | Glioblastoma Multiforme | ANXA5 | 0.29 | 0.07 | blup | 73 | 0.12 | 1.4e-04 | 6.1 | -5.7 | 9.8e-09 | -0.83 | 0.01 | 0.92 | FALSE |
22 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CCNA2 | 0.03 | 0.01 | blup | 34 | 0.02 | 1.5e-03 | -5.7 | 6.3 | 2.2e-10 | 0.12 | 0.00 | 0.97 | TRUE |
23 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | BBS7 | 0.04 | 0.04 | lasso | 2 | 0.03 | 6.1e-04 | -5.8 | -5.8 | 6.5e-09 | -0.12 | 0.00 | 1.00 | FALSE |
24 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ANXA5 | 0.22 | 0.29 | lasso | 7 | 0.30 | 3.9e-34 | 6.1 | -5.6 | 2.5e-08 | -0.88 | 0.08 | 0.92 | FALSE |
25 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | EXOSC9 | 0.03 | 0.02 | lasso | 2 | 0.02 | 1.0e-03 | 5.0 | 5.5 | 3.9e-08 | 0.06 | 0.08 | 0.35 | FALSE |
26 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | ANXA5 | 0.08 | 0.06 | lasso | 3 | 0.06 | 7.8e-05 | 6.1 | -6.1 | 1.1e-09 | -0.91 | 0.02 | 0.94 | FALSE |
27 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | ANXA5 | 0.23 | 0.24 | lasso | 7 | 0.22 | 2.7e-09 | 6.7 | -6.8 | 1.5e-11 | -0.99 | 0.00 | 1.00 | TRUE |
28 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ANXA5 | 0.05 | 0.03 | enet | 7 | 0.04 | 3.3e-05 | 5.2 | -6.1 | 1.2e-09 | -0.88 | 0.06 | 0.93 | FALSE |
29 | The Cancer Genome Atlas | Soft Tissue Sarcoma | ANXA5 | 0.06 | 0.03 | lasso | 3 | 0.03 | 9.8e-03 | 6.1 | -6.0 | 1.6e-09 | -0.93 | 0.02 | 0.81 | FALSE |
30 | The Cancer Genome Atlas | Thyroid Carcinoma | ANXA5 | 0.14 | 0.12 | lasso | 4 | 0.14 | 5.6e-14 | 6.1 | -6.2 | 5.4e-10 | -0.89 | 0.00 | 1.00 | FALSE |
31 | The Cancer Genome Atlas | Thyroid Carcinoma | EXOSC9 | 0.04 | 0.05 | lasso | 2 | 0.04 | 7.1e-05 | 4.5 | 5.4 | 7.1e-08 | 0.10 | 0.04 | 0.94 | FALSE |